ArticleBMC women's health2025
Reproductive history and cardiometabolic disease: the role of endogenous estrogen exposure across the lifespan in postmenopausal women.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Early in, early out: reproductive lifespan timing and cardiometabolic risk in women.Journal of endocrinological investigation · 2026Review
- Epigenome-Wide DNA Methylation Levels During Pregnancy: Associations with Parity Across Diverse Populations.Epigenomes · 2026Article
- Editorial: Sex hormones and cardiovascular-renal health: mechanisms, consequences, and therapeutic insights.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundThe association between cumulative endogenous estrogen exposure across the lifespan, especially considering reproductive events, and women's cardiometabolic health remain unclear. We aimed to examine the associations between lifetime endogenous estrogen exposure and the risks of diabetes, hypertension, and cardiovascular disease (CVD) among postmenopausal women.
methodsWe used baseline data from the Regional Ethnic Cohort Study in Northwest China. Reproductive factors were self-reported using a structured questionnaire, and surrogate indicators of estrogen exposures-reproductive lifespan, endogenous estrogen exposure, cumulative gestation duration and other proportional indicators-were calculated. Diabetes, hypertension and CVD were defined based on self-reported physician diagnoses at the hospital. Multivariable logistic regression models were employed to estimate adjusted odds rations (aORs) and 95% confidence intervals (CIs).
resultsAmong 35,498 postmenopausal women (median age 59.0 years [interquartile range: 54.0-65.0], each additional year of reproductive lifespan was associated with lower risks of diabetes (aOR 0.971; 95%CI 0.961, 0.982), hypertension (aOR 0.969; 95%CI 0.962, 0.975) and CVD (aOR 0.954; 95%CI 0.946, 0.962). Similar inverse associations were observed for endogenous estrogen exposure. In contrast, a higher ratio of gestation-to-reproductive lifespan duration was positively associated with increased risks of diabetes, hypertension, and CVD. Multiple incomplete pregnancies were associated with increased diabetes risk, while multiple complete pregnancies were linked to elevated risks of hypertension and CVD.
conclusionsLonger exposure to endogenous estrogen was associated with decreased risk of cardiometabolic disease, while a higher burden of gestational events was associated with increased risks. Reproductive history could be considered as an indicator for risk stratification and management of cardiometabolic disease in women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.